From: Association between tuberculin skin test result and clinical presentation of tuberculosis disease
Miliary disease | Pulmonary & Extrapulmonary disease | Extrapulmonary only disease | Cavitary pulmonary disease | ||||||
---|---|---|---|---|---|---|---|---|---|
aOR* | 95% CI* | aOR | 95% CI | aOR | 95% CI | aOR | 95% CI | ||
HIV+/US | |||||||||
0–4 mm | Ref | Ref | Ref | ||||||
5–9 mm | 0.96 | 0.47, 1.95 | 0.72 | 0.42, 1.22 | 1.29 | 0.81, 2.06 | 1.11 | 0.64, 1.94 | |
10–14 mm | 0.72 | 0.51, 1.01 | 0.81 | 0.65, 1.01 | 1.23 | 1.00, 1.53 | 1.36 | 1.07, 1.72 | |
≥ 15 mm | 0.50 | 0.37, 0.68 | 0.86 | 0.72, 1.03 | 1.09 | 0.91, 1.31 | 1.56 | 1.29, 1.90 | |
HIV+/FB | |||||||||
0–4 mm | Ref | Ref | Ref | Ref | |||||
5–9 mm | 0.18 | 0.02, 1.29 | 0.93 | 0.49, 1.79 | 1.01 | 0.53, 1.94 | 1.68 | 0.75, 3.75 | |
10–14 mm | 0.66 | 0.42, 1.04 | 0.80 | 0.60, 1.08 | 0.96 | 0.71, 1.28 | 1.85 | 1.27, 2.69 | |
≥ 15 mm | 0.59 | 0.40, 0.86 | 0.65 | 0.50, 0.84 | 1.16 | 0.92, 1.47 | 2.20 | 1.60, 3.02 | |
HIV-/US | |||||||||
0–4 mm | Ref | Ref | Ref | Ref | |||||
5–9 mm | 0.77 | 0.43, 1.38 | 1.09 | 0.78, 1.52 | 1.05 | 0.79, 1.39 | 1.32 | 1.11, 1.56 | |
10–14 mm | 0.49 | 0.37, 0.66 | 0.77 | 0.64, 0.91 | 1.05 | 0.92, 1.20 | 1.09 | 1.00, 1.18 | |
≥ 15 mm | 0.41 | 0.32, 0.53 | 0.80 | 0.70, 0.93 | 1.11 | 0.99, 1.24 | 1.11 | 1.03, 1.20 | |
HIV-/FB | |||||||||
0–4 mm | Ref | Ref | Ref | Ref | |||||
5–9 mm | 0.56 | 0.34, 0.93 | 0.61 | 0.43, 0.86 | 0.82 | 0.63, 1.06 | 0.84 | 0.69, 1.04 | |
10–14 mm | 0.22 | 0.16, 0.30 | 0.51 | 0.42, 0.62 | 0.85 | 0.74, 0.99 | 0.92 | 0.82, 1.03 | |
≥ 15 mm | 0.19 | 0.15, 0.25 | 0.56 | 0.48, 0.67 | 1.03 | 0.90, 1.17 | 0.81 | 0.73, 0.90 |